HBV News and Research

RSS
New drug to treat chronic hepatitis B

New drug to treat chronic hepatitis B

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B

Eleventh Edition of the Report on Carcinogens

Eleventh Edition of the Report on Carcinogens

Core promoter mutants of Hepatitis B Virus e Antigen associated with development of fulminant hepatitis and liver cancer

Core promoter mutants of Hepatitis B Virus e Antigen associated with development of fulminant hepatitis and liver cancer

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Prevalence of occult HBV in hemodialysis patients is 4 to 5 times higher than standard HBsAg testing would suggest

Prevalence of occult HBV in hemodialysis patients is 4 to 5 times higher than standard HBsAg testing would suggest

Liver transplantation outcomes have significantly improved for patients with hepatitis B

Liver transplantation outcomes have significantly improved for patients with hepatitis B

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Suspension of the initial dose of hepatitis B vaccine appears to have contributed to fewer newborns being vaccinated in 2000

Suspension of the initial dose of hepatitis B vaccine appears to have contributed to fewer newborns being vaccinated in 2000

FDA finalizes new rule on donor eligibility for human tissues and cells

FDA finalizes new rule on donor eligibility for human tissues and cells

Causes of hepatitis and potential therapies that may improve care presented in study

Causes of hepatitis and potential therapies that may improve care presented in study

Genencor Sells Its Therapeutic Vaccine Program to Innogenetics

Genencor Sells Its Therapeutic Vaccine Program to Innogenetics

Tiny Ribozyme package could be future treatment of Hepatitis B virus

Tiny Ribozyme package could be future treatment of Hepatitis B virus